4.51

1.35% 0.06

Abeona Therapeutics Inc (ABEO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Abeona Therapeutics Inc stock is traded at $4.51, with a volume of 2.11M. It is up +1.35% in the last 24 hours and down -16.17% over the past month. Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Previous Close:

$4.45

Open:

$4.4

24h Volume:

2.11M

Relative Volume:

1.44

Market Cap:

$228.19M

Revenue:

Net Income/Loss:

$-54.19M

P/E Ratio:

-1.7481

EPS:

-2.58

Net Cash Flow:

$-37.34M

1W Performance:

+6.62%

1M Performance:

-16.17%

6M Performance:

-26.07%

1Y Performance:

-23.04%

1-Day Range:

$4.39

$4.63

1-Week Range:

$4.12

$5.60

52-Week Range:

$3.9328

$7.5401

Abeona Therapeutics Inc Stock (ABEO) Company Profile

Name

Abeona Therapeutics Inc

Sector

Healthcare (1136)

Industry

Biotechnology (633)

Phone

646-813-4701

Address

6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY

Employee

136

Twitter

@abeonabio

Next Earnings Date

2024-12-11

Latest SEC Filings

ABEO's Discussions on Twitter

Compare ABEO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ABEO Abeona Therapeutics Inc	4.51	228.19M	0	-54.19M	-37.34M	-2.58
ARGX Argen X Se Adr	929.61	55.90B	3.06B	1.28B	447.35M	19.67
VRTX Vertex Pharmaceuticals Inc	434.02	110.91B	11.74B	3.68B	3.34B	14.19
INSM Insmed Inc	197.40	41.21B	447.02M	-1.18B	-906.14M	-6.1812
ONC Beone Medicines Ltd Adr	376.63	40.48B	4.98B	69.59M	525.67M	0.5197
REGN Regeneron Pharmaceuticals Inc	704.31	72.89B	14.25B	4.58B	3.88B	41.77

Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-02-25	Resumed	Oppenheimer	Outperform
Mar-05-25	Initiated	Oppenheimer	Outperform
Jul-03-24	Initiated	H.C. Wainwright	Buy
May-30-24	Initiated	Stifel	Buy
Nov-11-20	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Sep-18-20	Initiated	B. Riley FBR	Buy
Feb-10-20	Initiated	SVB Leerink	Outperform
Dec-10-19	Resumed	Cantor Fitzgerald	Neutral
Aug-15-19	Downgrade	Maxim Group	Buy → Hold
Aug-12-19	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jul-26-19	Downgrade	Mizuho	Buy → Neutral
Jun-27-19	Initiated	Mizuho	Buy
Oct-12-18	Initiated	Mizuho	Buy
Jun-05-18	Initiated	Seaport Global Securities	Buy
Nov-08-17	Initiated	SunTrust	Buy
Oct-16-17	Reiterated	H.C. Wainwright	Buy
Oct-11-17	Reiterated	Cantor Fitzgerald	Overweight
Oct-10-17	Initiated	Citigroup	Buy
Oct-05-17	Reiterated	Maxim Group	Buy
Sep-15-17	Initiated	RBC Capital Mkts	Outperform
Jul-18-17	Reiterated	Maxim Group	Buy
Jun-22-17	Resumed	Jefferies	Buy
Jan-06-17	Initiated	Jefferies	Buy
Sep-29-16	Reiterated	Maxim Group	Buy

View All

Abeona Therapeutics Inc Stock (ABEO) Latest News

Nov 17, 2025

How Abeona Therapeutics Inc. (PCJ) stock behaves in tightening cycles2025 Major Catalysts & Real-Time Volume Spike Alerts - newser.com

Nov 17, 2025

Nov 16, 2025

Is Abeona Therapeutics Inc a good long term investmentDividend Reinvestment Plans & Market-Leading Growth Rates - earlytimes.in

Nov 16, 2025

Is Abeona Therapeutics Inc. (PCJ) stock positioned for digital growth eraWeekly Investment Report & Fast Momentum Entry Tips - newser.com

Nov 16, 2025

Is Abeona Therapeutics Inc. (PCJ) stock supported by free cash flowJuly 2025 Summary & Real-Time Volume Analysis Alerts - newser.com

Nov 16, 2025

Sentiment analysis tools applied to Abeona Therapeutics Inc.Market Activity Recap & Community Verified Watchlist Alerts - newser.com

Nov 16, 2025

Sector ETF performance correlation with Abeona Therapeutics Inc.2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com

Nov 16, 2025

How Abeona Therapeutics Inc. stock reacts to inflationary pressuresMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com

Nov 16, 2025

Can Abeona Therapeutics Inc. (PCJ) stock survive global slowdownQuarterly Market Review & Weekly Return Optimization Plans - newser.com

Nov 16, 2025

Nov 14, 2025

Director’s Bold Move: Abeona Therapeutics Stock Sale Shakes Market! - TipRanks

Nov 14, 2025

Insider Sell Alert: Mark Alvino Sells 15,000 Shares of Abeona Th - GuruFocus

Nov 14, 2025

Visualizing Abeona Therapeutics Inc. stock with heatmaps2025 Risk Factors & Reliable Breakout Forecasts - newser.com

Nov 14, 2025

Nov 13, 2025

Abeona Therapeutics at Stifel 2025 Healthcare Conference: Strategic Progress and Challenges - Investing.com Canada

Nov 13, 2025

Abeona Therapeutics Earnings Call: Positive Outlook Amid Challenges - MSN

Nov 13, 2025

Abeona anticipates 2026 profitability as ZEVASKYN demand doubles and QTC network expands - MSN

Nov 13, 2025

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 13, 2025

Abeona Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates - MarketScreener

Nov 13, 2025

Abeona Therapeutics (ABEO) Is Up 17.9% After Reporting Narrowed Losses and ZEVASKYN J-code Approval - Yahoo Finance

Nov 13, 2025

Abeona Therapeutics: Q3 Earnings Snapshot - New Haven Register

Nov 13, 2025

Nov 12, 2025

Abeona Therapeutics: Q3 2025 Financial Insights - TipRanks

Nov 12, 2025

Is Abeona Therapeutics Inc. stock oversold or undervaluedMarket Growth Review & High Accuracy Buy Signal Tips - newser.com

Nov 12, 2025

Applying big data sentiment scoring on Abeona Therapeutics Inc.Gold Moves & Capital Efficient Trading Techniques - newser.com

Nov 12, 2025

Abeona (ABEO) Focuses on ZEVASKYN Launch amid Strong Demand - GuruFocus

Nov 12, 2025